Filing Details
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2009-06-02 13:05:00
- Reporting Period:
- 2009-06-01
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1047699 | King Pharmaceuticals Inc | KG | () |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1213334 | Charles Moyer | C/O King Pharmaceuticals, Inc. 501 Fifth Street Bristol TN 37620 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2009-06-01 | 6,000 | $9.48 | 24,512 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Billionaire Hedge Funds
